News
Triple reuptake inhibitors: What to expect from ‘mega-antidepressants’
- Author:
- Amanda M. Shaw, PhD
- Mona Boules, PhD
- Elliott Richelson, MD
Rapid onset of action could make serotonin-norepinephrine-dopamine reuptake blockers a clinically useful option for patients with depression